Search results
Better Health Care Newsletter - May 2024 | JD Supra
JD Supra· 16 hours agoFederal officials have capped the cost of insulin at $35 a month. For now, that gives relief only to patients 65 and older covered by Medicare. Big...
Florida Blue Medicare Advantage 2024 Review - NerdWallet
Nerdwallet· 4 days agoStar ratings are determined by the Centers for Medicare & Medicaid Services (CMS). Florida Blue...
Pfizer stock gains 7% after earnings beat, company calls dividend 'secure'
Yahoo Finance· 6 days agoEliquis represents nearly 14% of Pfizer’s Q1 revenue, and we recognize the uncertainty tied to the...
The Magnolia State must continue the fight for affordable medication
The Clarion Ledger via Yahoo News· 13 hours agoThe way in which prescription drug benefits are designed should be up to health plan sponsors – such as business owners – not Washington bureaucrats.
Blueprint Medicines Corporation (NASDAQ:BPMC) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoBlueprint Medicines Corporation (NASDAQ:BPMC) Q1 2024 Earnings Call Transcript May 2, 2024 Blueprint...
May 1, 2024, Letters to the Editor
The Record-Courier· 7 days agoZephyr Cove Resort previously leased from the Forest Service about a half mile of lakefront. Despite public objections, the Forest Service has now agreed...
GSK raises forecasts on strong vaccine, HIV drug sales
BioPharma Dive via Yahoo Finance· 6 days agoSales of the shingles vaccine Shingrix and the RSV shot Arexvy helped fuel quarterly revenue totals...
United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales
Zacks via Yahoo Finance· 5 days agoSales of Tyvaso DPI were driven by higher volumes and increased commercialization utilization of the...
Earnings call: GSK forecasts growth with strong Q1 performance
Investing.com· 4 days agoGSK (GSK) reported robust earnings for the first quarter, with a 13% increase in sales to £7.4...
Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
BioPharma Dive via Yahoo Finance· 6 days agoSales of the transthyretin amyloidosis treatment widely beat Wall Street forecasts in the first...